Evidence map›Paper›PMID 34045724›Full record

ArticleNature structural & molecular biology2021

Retinoic acid signaling is critical during the totipotency window in early mammalian development.

Ane Iturbide, Mayra L Ruiz Tejada Segura, Camille Noll, Kenji Schorpp, Ina Rothenaigner, Elias R Ruiz-Morales, Gabriele Lubatti, Ahmed Agami, Kamyar Hadian, Antonio Scialdone and 1 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Nature structural & molecular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 73 citations in OpenAlex.

  1. Review
  2. Retinoic acid in health and disease.Signal transduction and targeted therapy · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Challenges of studying signaling metabolites in early development.Nature structural & molecular biology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. A taste of one's own medicine:Frontiers in immunology · 2025
    Article
  18. Review
  19. Zscan4 mediates ubiquitination and degradation of the corepressor complex to promote chromatin accessibility in 2C-like cells.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Ane IturbideInstitute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany.
Mayra L Ruiz Tejada Segura *Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany.ORCID http://orcid.org/0000-0003-4217-4458
Camille Noll *Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany.
Kenji Schorpp *Assay Development & Screening Platform, Institute of Molecular Toxicology & Pharmacology (TOXI), Helmholtz Zentrum München, Neuherberg, Germany.
Ina RothenaignerAssay Development & Screening Platform, Institute of Molecular Toxicology & Pharmacology (TOXI), Helmholtz Zentrum München, Neuherberg, Germany.
Elias R Ruiz-MoralesInstitute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany.ORCID http://orcid.org/0000-0002-5801-6190
Gabriele LubattiInstitute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany.
Ahmed AgamiInstitute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany.ORCID http://orcid.org/0000-0002-1200-7555
Kamyar HadianAssay Development & Screening Platform, Institute of Molecular Toxicology & Pharmacology (TOXI), Helmholtz Zentrum München, Neuherberg, Germany.ORCID http://orcid.org/0000-0001-8727-2575
Antonio ScialdoneInstitute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany.ORCID http://orcid.org/0000-0002-4956-2843
Maria-Elena Torres-PadillaInstitute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, Munich, Germany. torres-padilla@helmholtz-muenchen.de.ORCID http://orcid.org/0000-0002-1020-2074
Helmholtz Zentrum München · DEWellcome Sanger Institute · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Totipotent cells hold enormous potential for regenerative medicine. Thus, the development of cellular models recapitulating totipotent-like features is of paramount importance. Cells resembling the totipotent cells of early embryos arise spontaneously in mouse embryonic stem (ES) cell cultures. Such '2-cell-like-cells' (2CLCs) recapitulate 2-cell-stage features and display expanded cell potential. Here, we used 2CLCs to perform a small-molecule screen to identify new pathways regulating the 2-cell-stage program. We identified retinoids as robust inducers of 2CLCs and the retinoic acid (RA)-signaling pathway as a key component of the regulatory circuitry of totipotent cells in embryos. Using single-cell RNA-seq, we reveal the transcriptional dynamics of 2CLC reprogramming and show that ES cells undergo distinct cellular trajectories in response to RA. Importantly, endogenous RA activity in early embryos is essential for zygotic genome activation and developmental progression. Overall, our data shed light on the gene regulatory networks controlling cellular plasticity and the totipotency program.

Indexed as

Gene Expression Regulation, DevelopmentalAcitretinAnimalsBlastocyst Inner Cell MassCell DifferentiationCells, CulturedDose-Response Relationship, DrugEmbryonic Stem CellsFemaleGene Regulatory NetworksGenes, ReporterIsotretinoinMaleMiceMice, Inbred C57BLMice, Inbred CBAAcitretinIsotretinoinLY2955303PiperazinesPyrazolesReceptors, Retinoic Acidretinoic acid binding protein I, cellularRetinoic Acid Receptor gammaRNA, MessengerRNA, Small InterferingTretinoin

Identifiers

PMID34045724
PMCPMC8195742
OpenAlexW3165513352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.